Compared with the control group, C2C12 myotubes in the C26 medium-treated group exhibited upregulation of proteins related to the “NF-κB signal pathway,” “Cell adhesion molecules,” “ECM-receptor interaction,” etc. These results were consistent with previous reports about the muscle atrophy in cancer cachexia. The gene discussed is NFKB1; the disease is cancer.